BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 21840177)

  • 1. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.
    Pedersen CA; Gibson CM; Rau SW; Salimi K; Smedley KL; Casey RL; Leserman J; Jarskog LF; Penn DL
    Schizophr Res; 2011 Oct; 132(1):50-3. PubMed ID: 21840177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
    Jarskog LF; Pedersen CA; Johnson JL; Hamer RM; Rau SW; Elliott T; Penn DL
    Schizophr Res; 2017 Jul; 185():88-95. PubMed ID: 28094169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single dose intranasal oxytocin on social cognition in schizophrenia.
    Davis MC; Lee J; Horan WP; Clarke AD; McGee MR; Green MF; Marder SR
    Schizophr Res; 2013 Jul; 147(2-3):393-7. PubMed ID: 23676253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.
    Bürkner PC; Williams DR; Simmons TC; Woolley JD
    Schizophr Bull; 2017 Oct; 43(6):1291-1303. PubMed ID: 28586471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.
    Lee MR; Wehring HJ; McMahon RP; Linthicum J; Cascella N; Liu F; Bellack A; Buchanan RW; Strauss GP; Contoreggi C; Kelly DL
    Schizophr Res; 2013 Apr; 145(1-3):110-5. PubMed ID: 23415472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural and behavioral effects of oxytocin administration during theory of mind in schizophrenia and controls: a randomized control trial.
    De Coster L; Lin L; Mathalon DH; Woolley JD
    Neuropsychopharmacology; 2019 Oct; 44(11):1925-1931. PubMed ID: 31103018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.
    Feifel D; Macdonald K; Nguyen A; Cobb P; Warlan H; Galangue B; Minassian A; Becker O; Cooper J; Perry W; Lefebvre M; Gonzales J; Hadley A
    Biol Psychiatry; 2010 Oct; 68(7):678-80. PubMed ID: 20615494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
    Lee MR; Wehring HJ; McMahon RP; Liu F; Linthicum J; Verbalis JG; Buchanan RW; Strauss GP; Rubin LH; Kelly DL
    Schizophr Res; 2016 Apr; 172(1-3):165-8. PubMed ID: 26879587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial.
    Halverson T; Jarskog LF; Pedersen C; Penn D
    Schizophr Res; 2019 Feb; 204():178-182. PubMed ID: 30243853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.
    Guastella AJ; Ward PB; Hickie IB; Shahrestani S; Hodge MA; Scott EM; Langdon R
    Schizophr Res; 2015 Nov; 168(3):628-33. PubMed ID: 26150070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial.
    Brambilla M; Cotelli M; Manenti R; Dagani J; Sisti D; Rocchi M; Balestrieri M; Pini S; Raimondi S; Saviotti FM; Scocco P; de Girolamo G
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1619-28. PubMed ID: 27527256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia.
    Gibson CM; Penn DL; Smedley KL; Leserman J; Elliott T; Pedersen CA
    Schizophr Res; 2014 Jul; 156(2-3):261-5. PubMed ID: 24799299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia.
    Feifel D; Macdonald K; Cobb P; Minassian A
    Schizophr Res; 2012 Aug; 139(1-3):207-10. PubMed ID: 22682705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin administration enhances controlled social cognition in patients with schizophrenia.
    Woolley JD; Chuang B; Lam O; Lai W; O'Donovan A; Rankin KP; Mathalon DH; Vinogradov S
    Psychoneuroendocrinology; 2014 Sep; 47():116-25. PubMed ID: 25001961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory top-down control and affective theory of mind in schizophrenia with and without hallucinations.
    Rominger C; Bleier A; Fitz W; Marksteiner J; Fink A; Papousek I; Weiss EM
    Schizophr Res; 2016 Jul; 174(1-3):192-196. PubMed ID: 27197903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial.
    Weiser M; Levi L; Burshtein S; Chiriță R; Cirjaliu D; Gonen I; Yolken R; Davidson M; Zamora D; Davis JM
    Schizophr Res; 2019 Apr; 206():325-332. PubMed ID: 30455075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial.
    İmamoğlu A; Stiles BJ; Jarskog LF; Pedersen CA; Elliott T; Penn DL
    J Psychiatr Res; 2024 Mar; 171():95-98. PubMed ID: 38262165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin-augmented social cognitive skills training in schizophrenia.
    Davis MC; Green MF; Lee J; Horan WP; Senturk D; Clarke AD; Marder SR
    Neuropsychopharmacology; 2014 Aug; 39(9):2070-7. PubMed ID: 24637803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.